Pictures from the WIPO SCCR negotiations on a treaty for persons who are blind or have other disabilities
These are pictures from the WIPO negotiations on a treaty for persons who are blind or have other disabilities.
 |
Author: James Love
Non paper distributed at SCCR 22 at 1pm on Friday, on disabilities
In a major breakthrough on the WIPO negotiations on copyright exceptions for persons with disabilities, at around 1pm today, a non-paper “resulting from informal discussions among Argentina, Brazil, Ecuador, the European Union and its Member States, Mexico, Paraguay and the United States of America” was distributed at the WIPO SCCR 22.
A copy of the document is available here:
/wp-content/uploads/text_distributed_friday_1pm.doc
Report from SCCR 22 discussions of WIPO treaty for persons who are blind or have other disabilities
 |
| Members of the WBU delegation at WIPO SCCR 22 |
June 16, 10 am: There are good news and less good news to report from Geneva. While overall, things have moved in positive directions, with the US and the EU engaged in very constructive negotiations with Brazil and other treaty sponsors, there are still many frustrations. Continue Reading
White House and European Commission trade official oppose waiver of drug patents for Least Developed Countries (LDCs)
Pharmaceutical global R&D was 7.9 percent of sales in 2010
Using industry assertions of R&D spending, pharmaceutical related R&D spending by the private sector was less than 8 percent of global sales in 2010.
These are the data:
2010 Global R&D by all private companies: – $67.4 billion
Source: Page 2 of the 2011 PhRMA industry profile
http://report.nih.gov/investigators_and_trainees/acd_bwf/pdf/Phrma_Industry_Profile_2011.pdf
2010 Global sales – $856 billion
Continue Reading
KEI Intervention at UN HLM on HIV: De-Linking R&D costs from drug prices and the sustainability of treatment
These are the notes from my intervention today at the UN’s High Level Meeting on HIV/AIDS in New York. The persons making statements from the floor were asked to keep their comments to two minutes, so the actual intervention was somewhat shorter. Jamie
the comprehensive review of the progress achieved in realizing
the Declaration of Commitment on HIV/AIDS and
Continue Reading
Draft of the Political Declaration on HIV and AIDS disappoints public health NGOs
Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other developing countries
KEI has received a copy of a May 16, 2011 letter from Karl De Gucht to Andris Piebalgs, which discusses (1) the EU-India FTA, and (2) Relations between IPR and development policies. Continue Reading
Senator Sanders introduces two medical innovation prize bills in U.S. Senate to de-link R&D costs from drug prices
On Thursday, May 26, 2011, Senator Bernie Sanders (I-VT) introduced two bills in the United States Senate that would de-link R&D costs from drug prices. The bill names and numbers are as follows:
USPTO statement at WIPO side event on Medicines Patent Pool
This is the statement that was delivered by Karin L. Ferriter (from USPTO and USTR), at a UNITAID side event on the Medicines Patent Pool, during a break of the WIPO Standing Committee on the Law of Patents.
Statement on Medicines Patent Pool Side Event